WallStreetZenWallStreetZen

NASDAQ: HROW
Harrow Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HROW past revenue growth

How has HROW's revenue growth performed historically?
Company
46.95%
Industry
9.98%
Market
17.61%
HROW's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HROW's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HROW's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HROW earnings and revenue history

Current Revenue
$130.2M
Current Earnings
-$24.4M
Current Profit Margin
-18.7%

HROW Return on Equity

Current Company
-51.2%
Current Industry
15.4%
Current Market
188%
HROW's Return on Equity (-51.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HROW announces earnings.

HROW Return on Assets

Current Company
-9.4%
Current Industry
3.4%
HROW is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HROW Return on Capital Employed

Current Company
-0.91%
Current Industry
5.1%
HROW has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HROW vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HROW$130.19M$9.95M-$24.41M+25.77%N/A
ORGO$433.14M$36.03M$4.95M+17.49%-90.86%
ESPR$116.33M-$150.11M-$209.25M-5.90%N/A
AQST$50.58M$1.18M-$7.87M-5.59%N/A
ACB$199.23M-$66.17M-$106.90M+17.87%N/A
View Top Pharmaceutical Stocks

HROW earnings dates

Next earnings date
May 9, 2024

Harrow Earnings & Revenue FAQ

What were HROW's earnings last quarter?

On Invalid Date, Harrow (NASDAQ: HROW) reported Q4 2023 earnings per share (EPS) of -$0.27, up 775% year over year. Total Harrow earnings for the quarter were -$9.15 million. In the same quarter last year, Harrow's earnings per share (EPS) was $0.04.

If you're new to stock investing, here's how to buy Harrow stock.

What was HROW's earnings growth in the past year?

As of Q2 2024, Harrow's earnings has grown year over year. Harrow's earnings in the past year totalled -$24.41 million.

What is HROW's earnings date?

Harrow's earnings date is Invalid Date. Add HROW to your watchlist to be reminded of HROW's next earnings announcement.

What was HROW's revenue last quarter?

On Invalid Date, Harrow (NASDAQ: HROW) reported Q4 2023 revenue of $36.36 million up 78.83% year over year. In the same quarter last year, Harrow's revenue was $20.33 million.

What was HROW's revenue growth in the past year?

As of Q2 2024, Harrow's revenue has grown 46.95% year over year. This is 36.98 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.98%. Harrow's revenue in the past year totalled $130.19 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.